E.E. Geduld’s Sage Therapeutics SAGE Stock Holding History

E.E. Geduld’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,000	Closed	-$803K	–	264
2015 Q2	$803K	Buy	11,000 +1,000	+10%	+$64.3K	0.5%	32
2015 Q1	$502K	Buy	+10,000	New	+$430K	0.34%	68

Other funds holding SAGE

TRV

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

E.E. Geduld's SAGE Position: Q3 2015 in Review

E.E. Geduld sold out of Sage Therapeutics (SAGE) in Q3 2015, closing a stake of 11,000 shares — an estimated $803K sold.

E.E. Geduld first reported a position in SAGE in Q1 2015 and held it in 2 quarters. The position peaked at $803K in Q2 2015. 135 funds tracked by Wall St. Rank hold SAGE as of Q3 2015.

E.E. Geduld reported no remaining Sage Therapeutics position as of Q3 2015 after selling out during the quarter.
E.E. Geduld sold 11,000 Sage Therapeutics shares in Q3 2015, an estimated $803K.
E.E. Geduld first reported a position in Sage Therapeutics in Q1 2015 and held it in 2 quarters.
E.E. Geduld's Sage Therapeutics position peaked at $803K in Q2 2015.
135 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2015.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.